Total Payments
$18,238
2024 Payments
$2,373
Companies
54
Transactions
1,242
Medicare Patients
15,610
Medicare Billing
$619,908
Payment Breakdown by Category
Food & Beverage$17,993 (98.7%)
Education$195.71 (1.1%)
Other$49.95 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,993 | 1,229 | 98.7% |
| Education | $195.71 | 12 | 1.1% |
| Long term medical supply or device loan | $49.95 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,982 | 174 | $0 (2024) |
| PFIZER INC. | $1,761 | 131 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,465 | 87 | $0 (2024) |
| Amgen Inc. | $1,206 | 80 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,180 | 71 | $0 (2024) |
| Lilly USA, LLC | $1,114 | 77 | $0 (2024) |
| ABBVIE INC. | $961.29 | 61 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $806.71 | 56 | $0 (2024) |
| GlaxoSmithKline, LLC. | $656.29 | 44 | $0 (2024) |
| Mylan Specialty L.P. | $517.28 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,373 | 130 | Novo Nordisk Inc ($290.47) |
| 2023 | $2,611 | 160 | Novo Nordisk Inc ($411.44) |
| 2022 | $2,522 | 155 | AstraZeneca Pharmaceuticals LP ($245.03) |
| 2021 | $2,436 | 161 | PFIZER INC. ($270.29) |
| 2020 | $2,488 | 175 | AstraZeneca Pharmaceuticals LP ($276.09) |
| 2019 | $2,238 | 171 | AstraZeneca Pharmaceuticals LP ($222.29) |
| 2018 | $2,157 | 164 | Novo Nordisk Inc ($268.01) |
| 2017 | $1,413 | 126 | Novo Nordisk Inc ($228.23) |
All Payment Transactions
1,242 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $15.96 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.89 | General |
| Category: GI | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.64 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Obesity | ||||||
| 12/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Diabetes Care | ||||||
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Insomnia | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Biological | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Abbott Laboratories | FREESTYLE INSULINX (Device) | Long term medical supply or device loan | In-kind items and services | $49.95 | General |
| Category: Diabetes Care | ||||||
| 10/24/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $99.85 | General |
| Category: NEUROLOGY | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Obesity | ||||||
| 10/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.97 | General |
| Category: GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 52 | 3,768 | 7,773 | $389,825 | $140,099 |
| 2022 | 59 | 3,947 | 7,932 | $429,375 | $159,692 |
| 2021 | 57 | 3,818 | 9,295 | $404,891 | $146,988 |
| 2020 | 62 | 4,077 | 8,435 | $494,265 | $173,129 |
Total Patients
15,610
Total Services
33,435
Medicare Billing
$619,908
Procedure Codes
230
All Medicare Procedures & Services
230 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 285 | 541 | $90,607 | $46,540 | 51.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 63 | 63 | $10,710 | $7,749 | 72.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 30 | 37 | $13,357 | $7,676 | 57.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 74 | $13,098 | $6,669 | 50.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 179 | 224 | $16,128 | $6,440 | 39.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 40 | 48 | $8,064 | $4,189 | 51.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 185 | 241 | $16,870 | $3,967 | 23.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 205 | 287 | $16,646 | $3,726 | 22.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 181 | 228 | $16,644 | $3,340 | 20.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 208 | 310 | $16,740 | $3,209 | 19.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 43 | 51 | $6,120 | $3,015 | 49.3% |
| 77067 | Screening mammography | Office | 2023 | 35 | 35 | $9,345 | $3,000 | 32.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 223 | 343 | $3,430 | $2,864 | 83.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 210 | 301 | $13,846 | $2,831 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 41 | $4,723 | $2,583 | 54.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 36 | 36 | $2,960 | $2,514 | 84.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 210 | 310 | $8,990 | $2,359 | 26.2% |
| 82746 | Folic acid level, serum | Office | 2023 | 132 | 155 | $11,935 | $2,205 | 18.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 14 | $3,598 | $2,203 | 61.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 190 | 247 | $15,067 | $2,157 | 14.3% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 11 | 12 | $9,432 | $2,098 | 22.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 23 | 23 | $4,025 | $1,477 | 36.7% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2023 | 17 | 17 | $6,800 | $1,466 | 21.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 62 | 73 | $4,891 | $1,297 | 26.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 27 | 32 | $4,480 | $1,261 | 28.2% |
About Mahendra Narendran
Mahendra Narendran is a Infectious Disease healthcare provider based in Statesville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1316074693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mahendra Narendran has received a total of $18,238 in payments from pharmaceutical and medical device companies, with $2,373 received in 2024. These payments were reported across 1,242 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($17,993).
As a Medicare-enrolled provider, Narendran has provided services to 15,610 Medicare beneficiaries, totaling 33,435 services with total Medicare billing of $619,908. Data is available for 4 years (2020–2023), covering 230 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Internal Medicine
- Location Statesville, NC
- Active Since 02/27/2007
- Last Updated 09/13/2012
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1316074693
Products in Payments
- FARXIGA (Drug) $952.24
- ELIQUIS (Drug) $858.91
- Ozempic (Drug) $715.08
- XARELTO (Drug) $703.04
- CHANTIX (Drug) $590.52
- JARDIANCE (Drug) $578.26
- STIOLTO RESPIMAT (Drug) $533.86
- XIFAXAN (Drug) $430.99
- UBRELVY (Drug) $423.43
- VRAYLAR (Drug) $421.50
- Livalo (Drug) $397.70
- Aimovig (Biological) $389.06
- TRULICITY (Drug) $363.34
- Yupelri (Drug) $356.01
- Wegovy (Drug) $328.55
- Linzess (Drug) $325.21
- Vascepa (Drug) $316.58
- TRELEGY ELLIPTA (Drug) $292.50
- Kerendia (Drug) $285.89
- ENTRESTO (Drug) $276.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.